NEW YORK, Oct. 16, 2017 -- WisdomTree (NASDAQ:WETF), an exchange-traded fund (“ETF”) and exchange-traded product (“ETP”) sponsor and asset manager, today announced that 72 of its U.S.-listed ETFs will be added to TD Ameritrade’s expanded commission-free ETF trading platform, effective tomorrow.
TD Ameritrade’s commission-free ETF program will provide registered investment advisor (RIA) and individual investor clients access to nearly 300 non-proprietary ETFs.
Kurt MacAlpine, WisdomTree Head of Global Distribution, said, “WisdomTree is very excited to be collaborating with TD Ameritrade on its new commission-free ETF program in such a prominent capacity. TD Ameritrade has continued to position itself as a market leader and industry disruptor delivering a robust client experience for independent advisors and retail investors. We are thrilled to be deepening our relationship with TD Ameritrade and its clients through this new program.”
Effective October 17th, investors using the TD Ameritrade platform will be able to purchase 72 of WisdomTree’s 87 ETFs without incurring the costs of trading commission fees. This commission-free access spans asset classes including equities, fixed income and alternatives, and includes a variety of investment categories in which WisdomTree is a smart beta ETF provider.
MacAlpine added, “We recognize the importance of offering lower cost investment options to investors. The breadth of WisdomTree smart beta ETFs included in this new program provides advisors and retail investors with the necessary building blocks to construct entire portfolios on the TD Ameritrade platform without incurring trading costs.”
Jim Dario, managing director of product management for TD Ameritrade Institutional, said, “We are excited to include WisdomTree as a provider in our expanded and enhanced commission-free ETF program. We believe our clients will benefit from the proprietary strategies they are delivering across asset classes, offering more ways for investors and advisers to express their market views.”
A complete list of the WisdomTree ETFs available on the TD Ameritrade platform is available here.
About WisdomTree
WisdomTree Investments, Inc., through its subsidiaries in the U.S., Europe, Japan and Canada (collectively, “WisdomTree”), is an exchange-traded fund (“ETF”) and exchange-traded product (“ETP”) sponsor and asset manager headquartered in New York. WisdomTree offers products covering equities, fixed income, currencies, commodities and alternative strategies. WisdomTree currently has approximately $46.9 billion in assets under management globally. For more information, visit our Investor Relations website.
WisdomTree® is the marketing name for WisdomTree Investments, Inc. and its subsidiaries worldwide.
About TD Ameritrade Holding Corporation
Millions of investors and independent registered investment advisors (RIAs) have turned to TD Ameritrade’s (Nasdaq:AMTD) technology, people and education to help make investing and trading easier to understand and do. Online or over the phone. In a branch or with an independent RIA. First-timer or sophisticated trader. Our clients want to take control, and we help them decide how - bringing Wall Street to Main Street for more than 40 years. TD Ameritrade has time and again been recognized as a leader in investment services. Please visit TD Ameritrade’s newsroom or www.amtd.com for more information, or read our stories at Fresh Accounts.
ETFs are subject to risk similar to those of their underlying securities, including, but not limited to, market, investment, sector, or industry risks, and those regarding short-selling and margin account maintenance. Some ETFs may involve international risk, currency risk, commodity risk, leverage risk, credit risk, and interest rate risk. Performance may be affected by risks associated with non-diversification, including investments in specific countries or sectors. Additional risks may also include, but are not limited to, investments in foreign securities, especially emerging markets, real estate investment trusts (REITs), fixed income, small-capitalization securities, and commodities. Each individual investor should consider these risks carefully before investing in a particular security or strategy. Investment returns will fluctuate and are subject to market volatility, so that an investor’s shares, when redeemed or sold, may be worth more or less than their original cost. Unlike mutual funds, shares of ETFs are not individually redeemable directly with the ETF. Shares are bought and sold at market price, which may be higher or lower than the net asset value (NAV).
TD Ameritrade receives remuneration from certain ETFs (exchange-traded funds) and/or ETF sponsors that participate in the commission-free ETF program for shareholder, administrative and/or other services.
WisdomTree Contact Information
Media Relations
WisdomTree Investments, Inc.
Jessica Zaloom / Kylie Scott
+1.917.267.3735 / +1.917.267.3860
[email protected] / [email protected]
Investor Relations
WisdomTree Investments, Inc.
Jason Weyeneth, CFA
+1.917.267.3858
[email protected]


SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support 



